DarioHealth Announces Q2 2026 Results Conference Call for Investors
DarioHealth Set to Share Q2 2026 Financial Results
DarioHealth Corp. (Nasdaq: DRIO), a pioneering force in AI-driven healthcare technology, has announced its plans to disclose its financial results for the second quarter of 2026. Investors and stakeholders are invited to join a conference call and webcast scheduled for August 11, 2026, at 8:30 AM ET. This event is an important opportunity for the company to communicate its performance and strategic direction in the evolving landscape of healthcare.
The call will feature key leadership from DarioHealth, including Erez Raphael, the Chief Executive Officer, Lara Dodo, Chief Operations Officer, and Chen Franco-Yehuda, Chief Financial Officer. They will present insights into the company’s achievements and the impact of its innovative solutions on chronic condition management.
Conference Call Details
Participants can join the call by using the following dial-in numbers:
- - Domestic: 1-800-717-1738
- - International: 1-646-307-1865
The webcast can be accessed here. Participants are encouraged to dial in approximately 10 minutes early to ensure a prompt start.
A replay of the conference call will be provided approximately three hours post-event and will be accessible until August 25, 2026. The details to listen to the replay include:
- - Domestic: 1-844-512-2921
- - International: 1-412-317-6671
About DarioHealth Corp.
Founded with the aim of transforming the management of chronic diseases, DarioHealth has established itself as a leader in providing AI-enhanced healthcare solutions. The company's platform integrates connected devices, personalized engagement, and clinical support to improve health outcomes while effectively managing costs for users, including health plans and employers.
DarioHealth's offerings stem from a robust database, boasting over 13 billion proprietary healthcare data points curated over more than a decade. By applying advanced AI analysis to biometric, clinical, and behavioral data, the company tailors interventions at the individual level. This comprehensive approach enables effective management of various chronic conditions, ranging from diabetes to hypertension and mental health challenges.
Investors looking to gain insight into DarioHealth’s performance and future initiatives should not miss this opportunity to engage with executive leadership. The upcoming conference call serves as a critical avenue for transparent communication regarding the company's ongoing commitment to innovation in healthcare technology.
Cautionary Note
This announcement contains forward-looking statements as defined in the Private Securities Litigation Reform Act of 1995. These statements involve risks and uncertainties, with actual results differing materially from projections. Factors impacting these outcomes include regulatory approvals, market acceptance, competitive dynamics, and more. Readers are advised to factor in these uncertainties when interpreting the company's future performance.
For additional information or queries, please contact:
- - Zoe Harrison, VP of Accounting and Corporate Development
- - Michael Lipari, SVP of Corporate Development
Both contacts can be reached via email through DarioHealth’s official communication channels.
Stay tuned for the financial results and further updates as DarioHealth continues to innovate within the healthcare landscape.
Topics Health）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.